Helix Nanotechnologies
YC W17 ↗Boston, US · 22 employees · 13 known investors
Helix Nanotechnologies develops mRNA-based therapeutics for disease treatment and environmental applications, currently advancing a COVID-19 vaccine candidate for immunocompromised patients and testing interventions targeting climate challenges.
AI & Machine LearningBiotechHealthtechArtificial IntelligenceGenomicsNanotechnologyin /company@helixnanoycombinator.com ↗
Founders & leadership· Y Combinator alumni (W17)
NE
Nikolai EroshenkoinFounder/CSO
Investors · 13
Beast VenturesHong Kong
Champion Hill Ventures$500K – $1M
Fifty YearsSan Francisco · $250K – $2M
Lifeline VenturesHelsinki
LongeVCWashington D.C.
MetaplanetTallinn · $500K – $10M
SGH CapitalParis
The Venture CollectiveMiami Beach · $100K – $2M
Y CombinatorSan Francisco · $500K
Yes VCSan Francisco · $30K – $1.5M
DCVC (Data Collective)reportedPalo Alto · $5M – $25M
OS FundreportedPark Ridge · $1M – $2M
Starlight VenturesreportedMiami · $100K – $3M